Alnylam Pharmaceuticals, Inc.

Swiss Life Asset Management Ltd ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/4/2026

Shares

22,472

Value ($000)

8,936

Weight

0.0%

2022 Q2 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/4/2026	8,936	0.0%	22,472	12/31/2025
2025 Q2	12/2/2025	7,757	0.0%	23,789	6/30/2025
2025 Q1	12/2/2025	2,649	0.0%	9,810	3/31/2025
2024 Q4	12/9/2025	3,013	0.0%	12,814	12/31/2024
2024 Q3	12/9/2025	995	0.0%	3,620	9/30/2024
2024 Q2	12/9/2025	474	0.0%	1,949	6/30/2024
2023 Q4	12/9/2025	654	0.0%	3,410	12/31/2023
2023 Q3	12/9/2025	741	0.0%	4,188	9/30/2023
2023 Q2	12/9/2025	821	0.0%	4,317	6/30/2023
2023 Q1	12/9/2025	870	0.0%	4,342	3/31/2023
2022 Q4	12/9/2025	953	0.0%	3,997	12/31/2022
2022 Q3	12/9/2025	352	0.0%	1,759	9/30/2022
2022 Q2	12/9/2025	273	0.0%	1,867	6/30/2022